|
1
|
Martinon F, Mayor A and Tschopp J: The
inflammasomes: guardians of the body. Annu Rev Immunol. 27:229–265.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Franchi L, Eigenbrod T and Núñez G:
Cutting edge: TNF-alpha mediates sensitization to ATP and silica
via the NLRP3 inflammasome in the absence of microbial stimulation.
J Immunol. 183:792–796. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jin C and Flavell RA: Molecular mechanism
of NLRP3 inflammasome activation. J Clin Immunol. 30:628–631. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Conforti-Andreoni C, Ricciardi-Castagnoli
P and Mortellaro A: The inflammasomes in health and disease: from
genetics to molecular mechanisms of autoinflammation and beyond.
Cell Mol Immunol. 8:135–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schroder K and Tschopp J: The
inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen M, Wang H, Chen W and Meng G:
Regulation of adaptive immunity by the NLRP3 inflammasome. Int
Immunopharmacol. 11:549–554. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leemans JC, Cassel SL and Sutterwala FS:
Sensing damage by the NLRP3 inflammasome. Immunol Rev. 243:152–162.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davis BK, Wen H and Ting JP: The
inflammasome NLRs in immunity, inflammation, and associated
diseases. Annu Rev Immunol. 29:707–735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cassel SL, Joly S and Sutterwala FS: The
NLRP3 inflammasome: a sensor of immune danger signals. Semin
Immunol. 21:194–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsu HY and Wen MH:
Lipopolysaccharide-mediated reactive oxygen species and signal
transduction in the regulation of interleukin-1 gene expression. J
Biol Chem. 277:22131–22139. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mariathasan S, Weiss DS, Newton K, McBride
J, O’Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM and
Dixit VM: Cryopyrin activates the inflammasome in response to
toxins and ATP. Nature. 440:228–232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van de Veerdonk FL and Netea MG: New
insights in the immunobiology of IL-1 family members. Front
Immunol. 4:1672013.PubMed/NCBI
|
|
13
|
Qi J, Ye X, Ren G, Kan F, Zhang Y, Guo M,
Zhang Z and Li D: Pharmacological efficacy of anti-IL-1β scFv, Fab
and full-length antibodies in treatment of rheumatoid arthritis.
Mol Immunol. 57:59–65. 2014.
|
|
14
|
Voronov E, Dayan M, Zinger H, Gayvoronsky
L, Lin JP, Iwakura Y, Apte RN and Mozes E: IL-1 beta-deficient mice
are resistant to induction of experimental SLE. Eur Cytokine Netw.
17:109–116. 2006.PubMed/NCBI
|
|
15
|
Girardin SE: Knocking in the NLRP3
inflammasome. Immunity. 30:761–763. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Latz E: The inflammasomes: mechanisms of
activation and function. Curr Opin Immunol. 22:28–33. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Budai MM, Varga A, Milesz S, Tozser J and
Benko S: Aloe vera downregulates LPS-induced inflammatory cytokine
production and expression of NLRP3 inflammasome in human
macrophages. Mol Immunol. 56:471–479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hussen J, Düvel A, Koy M and Schuberth HJ:
Inflammasome activation in bovine monocytes by extracellular ATP
does not require the purinergic receptor P2X7. Dev Comp Immunol.
38:312–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pétrilli V, Papin S, Dostert C, Mayor A,
Martinon F and Tschopp J: Activation of the NALP3 inflammasome is
triggered by low intracellular potassium concentration. Cell Death
Differ. 14:1583–1589. 2007.PubMed/NCBI
|
|
20
|
Kawai T and Akira S: Innate immune
recognition of viral infection. Nat Immunol. 7:131–137. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bose S and Banerjee AK: Innate immune
response against nonsegmented negative strand RNA viruses. J
Interferon Cytokine Res. 23:401–412. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O’Neill LA and Bowie AG: Sensing and
signaling in antiviral innate immunity. Curr Biol. 20:R328–R333.
2010.PubMed/NCBI
|
|
23
|
Rathinam VA and Fitzgerald KA:
Inflammasomes and anti-viral immunity. J Clin Immunol. 30:632–637.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ciraci C, Janczy JR, Sutterwala FS and
Cassel SL: Control of innate and adaptive immunity by the
inflammasome. Microbes Infect. 14:1263–1270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mankan AK, Dau T, Jenne D and Hornung V:
The NLRP3/ASC/Caspase-1 axis regulates IL-1beta processing in
neutrophils. Eur J Immunol. 42:710–715. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamasaki K, Muto J, Taylor KR, Cogen AL,
Audish D, Bertin J, Grant EP, Coyle AJ, Misaghi A, Hoffman HM and
Gallo RL: NLRP3/cryopyrin is necessary for interleukin-1beta
(IL-1beta) release in response to hyaluronan, an endogenous trigger
of inflammation in response to injury. J Biol Chem.
284:12762–12771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Halle A, Hornung V, Petzold GC, Stewart
CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ and
Golenbock DT: The NALP3 inflammasome is involved in the innate
immune response to amyloid-beta. Nat Immunol. 9:857–865. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou R, Tardivel A, Thorens B, Choi I and
Tschopp J: Thioredoxin-interacting protein links oxidative stress
to inflammasome activation. Nat Immunol. 11:136–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dostert C, Pétrilli V, Van Bruggen R,
Steele C, Mossman BT and Tschopp J: Innate immune activation
through Nalp3 inflammasome sensing of asbestos and silica. Science.
320:674–677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hornung V, Bauernfeind F, Halle A, Samstad
EO, Kono H, Rock KL, Fitzgerald KA and Latz E: Silica crystals and
aluminum salts activate the NALP3 inflammasome through phagosomal
destabilization. Nat Immunol. 9:847–856. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cassel SL, Eisenbarth SC, Iyer SS, Sadler
JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA and
Sutterwala FS: The Nalp3 inflammasome is essential for the
development of silicosis. Proc Natl Acad Sci USA. 105:9035–9040.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eisenbarth SC, Colegio OR, O’Connor W,
Sutterwala FS and Flavell RA: Crucial role for the Nalp3
inflammasome in the immunostimulatory properties of aluminium
adjuvants. Nature. 453:1122–1126. 2008. View Article : Google Scholar
|
|
33
|
Feldmeyer L, Keller M, Niklaus G, Hohl D,
Werner S and Beer HD: The inflammasome mediates UVB-induced
activation and secretion of interleukin-1beta by keratinocytes.
Curr Biol. 17:1140–1145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bryant C and Fitzgerald KA: Molecular
mechanisms involved in inflammasome activation. Trends Cell Biol.
19:455–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McGettrick AF and O’Neill LA: NLRP3 and
IL-1beta in macrophages as critical regulators of metabolic
diseases. Diabetes Obes Metab. 15(Suppl 3): 19–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lamkanfi M and Dixit VM: Inflammasomes:
guardians of cytosolic sanctity. Immunol Rev. 227:95–105. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
McCall SH, Sahraei M, Young AB, Worley CS,
Duncan JA, Ting JP and Marriott I: Osteoblasts express NLRP3, a
nucleotide-binding domain and leucine-rich repeat region containing
receptor implicated in bacterially induced cell death. J Bone Miner
Res. 23:30–40. 2008. View Article : Google Scholar
|
|
38
|
Duncan JA, Bergstralh DT, Wang Y,
Willingham SB, Ye Z, Zimmermann AG and Ting JP: Cryopyrin/NALP3
binds ATP/dATP, is an ATPase, and requires ATP binding to mediate
inflammatory signaling. Proc Natl Acad Sci USA. 104:8041–8046.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Faustin B, Lartigue L, Bruey JM, Luciano
F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein D, Rouiller I
and Reed JC: Reconstituted NALP1 inflammasome reveals two-step
mechanism of caspase-1 activation. Mol Cell. 25:713–724. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Srinivasula SM, Poyet JL, Razmara M, Datta
P, Zhang Z and Alnemri ES: The PYRIN-CARD protein ASC is an
activating adaptor for caspase-1. J Biol Chem. 277:21119–21122.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stehlik C, Lee SH, Dorfleutner A,
Stassinopoulos A, Sagara J and Reed JC: Apoptosis-associated
speck-like protein containing a caspase recruitment domain is a
regulator of procaspase-1 activation. J Immunol. 171:6154–6163.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bryan NB, Dorfleutner A, Kramer SJ, Yun C,
Rojanasakul Y and Stehlik C: Differential splicing of the
apoptosis-associated speck like protein containing a caspase
recruitment domain (ASC) regulates inflammasomes. J Inflamm (Lond).
7:232010. View Article : Google Scholar
|
|
43
|
Bryan NB, Dorfleutner A, Rojanasakul Y and
Stehlik C: Activation of inflammasomes requires intracellular
redistribution of the apoptotic speck-like protein containing a
caspase recruitment domain. J Immunol. 182:3173–3182. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Franchi L1, Eigenbrod T, Muñoz-Planillo R
and Nuñez G: The inflammasome: a caspase-1-activation platform that
regulates immune responses and disease pathogenesis. Nat Immunol.
10:241–247. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Martinon F and Tschopp J: Inflammatory
caspases: linking an intracellular innate immune system to
autoinflammatory diseases. Cell. 117:561–574. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Arend WP, Palmer G and Gabay C: IL-1,
IL-18, and IL-33 families of cytokines. Immunol Rev. 223:20–38.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schmitz J, Owyang A, Oldham E, Song Y,
Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X,
Gorman DM, Bazan JF and Kastelein RA: IL-33, an interleukin-1-like
cytokine that signals via the IL-1 receptor-related protein ST2 and
induces T helper type 2-associated cytokines. Immunity. 23:479–490.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cayrol C and Girard JP: The IL-1-like
cytokine IL-33 is inactivated after maturation by caspase-1. Proc
Natl Acad Sci USA. 106:9021–9026. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bae S, Kang T, Hong J, Lee S, Choi J, Jhun
H, Kwak A, Hong K, Kim E, Jo S and Kim S: Contradictory functions
(activation/termination) of neutrophil proteinase 3 enzyme (PR3) in
interleukin-33 biological activity. J Biol Chem. 287:8205–8213.
2012. View Article : Google Scholar
|
|
50
|
Lefrancais E, Roga S, Gautier V,
Gonzalez-de-Peredo A, Monsarrat B, Girard JP and Cayrol C: IL-33 is
processed into mature bioactive forms by neutrophil elastase and
cathepsin G. Proc Natl Acad Sci USA. 109:1673–1678. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shaw PJ, McDermott MF and Kanneganti TD:
Inflammasomes and autoimmunity. Trends Mol Med. 17:57–64. 2011.
View Article : Google Scholar : PubMed/NCBI
|
